ClinicalTrialsFinder
RecruitingNot ApplicableNCT07150858

Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

Comparison Between Erythropoietin-enhanced Albumin Platelet-rich Fibrin and Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

Sponsor

Alexandria University

Enrollment

20 participants

Start Date

May 25, 2025

Study Type

INTERVENTIONAL

Conditions

Sinus Lifting

Summary

Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma. Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla. Methods: This study will be carried out as a randomized

Eligibility

Min Age: 20 YearsMax Age: 60 Years

Inclusion Criteria4

  • Residual bone height not less than 5 mm measured from crestal bone to sinus floor.
  • Both genders.
  • Good oral hygiene
  • No previous surgery or radiation treatment on the maxillary sinus

Exclusion Criteria9

  • Recent radiation therapy in maxilla.
  • Uncontrolled systemic diseases such as diabetes mellitus.
  • Heavy smoker (those who smoke ≥ 25 cigarettes a day).
  • Alcohol abuse.
  • Patient on anticoagulant drug
  • Severe allergic rhinitis.
  • Tumor or large cyst in the maxillary sinus.
  • Oroantral fistula.
  • Presence of acute or chronic sinus pathoses or sinus membrane perforation.(

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERErythropoietin and albumin PRF gel + implant placement

This group will be treated by transcrestal sinus lifting with erythropoietin and albumin PRF gel with simultaneous implant placement.

OTHERAlbumin PRF gel +implant placement

This group (the Control group) will be treated with transcrestal sinus lifting using albumin PRF gel, with simultaneous implant placement.

Locations(1)

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University

Alexandria, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07150858